MedPath

Ayurveda intervention as Prophylactic trial against COVID-19

Phase 2
Registration Number
CTRI/2020/05/025171
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Either sex aged 19-60 years

2.Who are on duty in different units and districts of Delhi state.

3.Who agrees to give consent for participation and

4.Who agrees not to take any other prophylactic medicines during the trial period.

Exclusion Criteria

1.Already suffering with severe respiratory allergies and other conditions which may create bias in the outcome results

2.Those who will be infected with COVID-19 recently within 1 month

3. Individuals found positive for IgG COVID-19

4. Subjects on other prophylactic medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change in immune status score using ISQ, will be assessed at baseline (day 0), after 60days of intervention <br/ ><br> <br/ ><br>2. Change in IgG COVID-19 Positivity by COVID specific IgG. <br/ ><br> <br/ ><br>Timepoint: baseline (day 0), and after 60days <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life (SF-36 proforma will be used)Timepoint: 12 week
© Copyright 2025. All Rights Reserved by MedPath